COMP <GO>
PCAR vs PG // RSI-14 & 200D SMA MOMENTUM
PACCAR Inc. (NASDAQ) VS. Procter & Gamble Company (The) (NYSE) • 15-METRIC TALLY: PCAR 4
— PG 11
▲ RSI-14 & 200D SMA MOMENTUM LEADER: PG
LAST: $101.91 (-0.37%) • MKT CAP: $53.86B
rsi-technicals
25.1
LAST: $161.57 (+0.61%) • MKT CAP: $372.21B
rsi-technicals
62.7
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (PCAR VS. PG)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | PCAR | PG | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 20.10% | 51.20% | -31.10 | PG | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 10.00% | 25.40% | -15.40 | PG | /roic <GO> |
| EV/EBITDA & P/E Valuation | 16.3x | 16.2x | +0.10 | PG | /valuation <GO> |
| Free Cash Flow Yield | 6.82% | 3.77% | +3.05 | PCAR | /fcf-yield <GO> |
| Operating Margin | 10.20% | 24.30% | -14.10 | PG | /operating-margins <GO> |
| Net Profit Margin | 8.40% | 19.00% | -10.60 | PG | /net-margins <GO> |
| Revenue Growth (YoY) | -15.50% | 0.30% | -15.80 | PG | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 4.21% | 2.65% | +1.56 | PCAR | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 3.23 | 5.59 | -2.36 | PG | /balance-sheet <GO> |
| Piotroski F-Score Quality | 6/9 | 7/9 | -1.00 | PG | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 7.40% | 6.50% | +0.90 | PG | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum ACTIVE | 25.1 | 62.7 | -37.56 | PG | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.16 | 0.87 | +0.29 | PCAR | /macro-sensitivity <GO> |
| Forward P/E Multiple | 21.1x | 21.7x | -0.60 | PCAR | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $53.86B | $372.21B | -$318.36B | PG | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | PCAR REV | PG REV | PCAR GROSS % | PG GROSS % | PCAR FCF | PG FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $28.44B | $84.28B | 20.1% | 51.2% | $3.67B | $14.04B |
| FY 2024 | $33.66B | $84.04B | 22.6% | 51.4% | $3.80B | $16.52B |
| FY 2023 | $35.13B | $82.01B | 44.0% | 44.0% | $2.61B | $13.16B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
PCAR // BETA 1.16
PG // BETA 0.87